Maria Vita Sanò

6PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 15, 2026
A Real-World Study on the Effectiveness and Safety of Elacestrant in Patients with ESR1-Mutated Metastatic Breast Cancer Progressing After CDK4/6 Inhibitors and Endocrine Therapy.

|Dec 11, 2025
High-Risk Node-Positive Hormone Receptor-Positive/HER2-Low Breast Cancer Relapse on Adjuvant Abemaciclib Treatment with ER Loss at Metastatic Recurrence: A Case Report and Literature Review.

Maria Vita Sanò, Lorenza Marino, Maria Puleo

|Sep 13, 2025
Could 18F-FES PET Be a New Driver in Therapeutic Choice for Metastatic HR+/HER2- Patients?

Maria Vita Sanò, Alessandro Russo, Lorenza Marino

|Aug 22, 2025
Sustained Complete Response to Trastuzumab Deruxtecan Beyond Treatment Discontinuation in a Heavily Pretreated HER2-Positive Breast Cancer Patient with Skin Metastases: A Case Report.

Maria Puleo, Sarah Pafumi, Martina Di Pietro

|Jul 28, 2025
Correlation between histopathological features and recurrence score according to menopausal status in HR+/HER2- breast cancer patients: a retrospective study.

Federica Martorana, Sabrina Nucera, Gianmarco Motta

|Jul 12, 2025
Efficacy and Safety Analysis of Nab-Paclitaxel Treatment in Elderly Patients with HER-2 Negative Metastatic Breast Cancer: NEREIDE Study.

Giuseppina Rosaria Rita Ricciardi, Alessandro Russo, Maria Vita Sanò

Pageof 1

Frequent Collaborators

4 joint publications

Giuseppina Rosaria Rita Ricciardi

2 joint publications

Alessandro Russo

2 joint publications

Vittorio Gebbia

2 joint publications

Stefano Marletta